Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019.
Intern Med
; 59(18): 2327-2329, 2020 Sep 15.
Article
in English
| MEDLINE | ID: covidwho-792260
ABSTRACT
A 42-year-old man exhibiting hypoxia was diagnosed with coronavirus disease 2019. He had medical histories of type 2 diabetes, hyperlipidemia, hyperuricemia, and gout attack. He received favipiravir for compassionate use for 14 days. Subsequently, he showed increased uric acid levels and developed acute gouty arthritis. Favipiravir may induce not only hyperuricemia but also acute gouty arthritis. It should therefore be used with caution in patients with a history of gout and those with hyperuricemia, especially when used at a higher dose and for a longer duration than is typical.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Pyrazines
/
Arthritis, Gouty
/
Coronavirus Infections
/
Betacoronavirus
/
Amides
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Intern Med
Journal subject:
Internal Medicine
Year:
2020
Document Type:
Article
Affiliation country:
Internalmedicine.5377-20
Similar
MEDLINE
...
LILACS
LIS